evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/geneAliases/3,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract
5857,GENE_SUMMARY,,"AXL, a receptor tyrosine kinase, is altered by mutation, amplification or overexpression in various cancers.",,2017-10-23,,558,AXL,AXL receptor tyrosine kinase,True,ENST00000301178,NM_021913.4,ARK,JTK11,Tyro7,UFO,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
5858,GENE_BACKGROUND,,"AXL encodes a receptor tyrosine kinase whose ligand is the vitamin K-dependent growth factor, GAS6. Signaling through AXL mediates proliferation, survival and chemoresistance in AXL-expressing cells (PMID: 23982172). This paracrine signaling axis regulates such diverse cellular functions through activation of the MAPK/ERK and PI3K/AKT signaling pathways (PMID: 18620092). Additionally, AXL has been shown to be essential to the epithelial-to-mesenchymal transition, thereby regulating breast cancer metastasis (PMID: 16585512). AXL is overexpressed in many human cancers including lung, breast and pancreatic cancer, and is a chronic myelogeneous leukemia-associated oncogene (PMID: 1656220). Currently, inhibitors specifically targeting AXL or multi-targeted kinase inhibitors with good potency against AXL are under clinical development (PMCID: PMC4259419).",,2017-04-21,,558,AXL,AXL receptor tyrosine kinase,True,ENST00000301178,NM_021913.4,ARK,JTK11,Tyro7,UFO,False,18620092,"TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer.",Advances in cancer research,2008,100,,35-83,Linger RM et al,doi: 10.1016/S0065-230X(08)00002-X,,Linger RM et al. Advances in cancer research. 2008;100()35-83.,,1656220,"axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase.",Molecular and cellular biology,0001-10-01,11,10,5016-31,O'Bryan JP et al,,,0001-10-01,,23982172,"Axl, a prognostic and therapeutic target in acute myeloid leukemia mediates paracrine crosstalk of leukemia cells with bone marrow stroma.",Blood,2018-10-03T20:13:00,122,14,2443-52,Ben-Batalla I et al,doi: 10.1182/blood-2013-03-491431,,0001-10-03,,16585512,Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival.,Proceedings of the National Academy of Sciences of the United States of America,2018-04-11T20:06:00,103,15,5799-804,Vajkoczy P et al,,,2018-04-11T08:04:00,
